Atomizing Nozzle Depth Control and Disposable Design

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nasal drug delivery devices face issues with accurate depth control of the atomizing nozzle, leading to potential nasal cavity damage and contamination due to repeated use, especially when administering medication to children or individuals who cannot accurately guide the nozzle.

Innovation Solution

The design incorporates a spray hood with a conical shape and a connecting cylinder featuring a bayonet or claw structure for secure snap-fit attachment to the syringe, along with a fluid-guiding cylinder and fan-shaped projections for precise spray control, ensuring the nozzle extends only as far as necessary and is used once to prevent contamination.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the atomizing nozzle is reused multiple times to deliver medication, then the productivity of the device is improved, but the reliability is worsened due to contamination with bacteria and viruses

Engineering Contradiction:
Improvenumber of usesVSAvoidcontamination risk
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent implements a disposable atomizing nozzle that is discarded after a single use. The nozzle is pre-attached to a medication container and cannot be removed for reuse. This eliminates contamination risk from repeated use while maintaining productivity by providing a new sterile nozzle for each medication delivery session.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Reliability

If the nozzle is extended deep into the nasal cavity to deliver medication effectively, then the effectiveness is improved, but the object-affected harmful factors worsen due to potential damage to the nasal cavity

Engineering Contradiction:
Improvedrug delivery effectivenessVSAvoidnasal cavity damage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent designs the nozzle with a specific geometric configuration including a conical expansion section and a columnar end section with precisely controlled dimensions. The columnar end has a diameter of 1-3mm and length of 5-15mm, creating a localized interaction zone that delivers medication effectively while limiting penetration depth to avoid nasal cavity damage.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The nozzle geometry is pre-designed with built-in depth control features before use. The columnar end section and conical expansion create a physical stop that prevents over-insertion. This preliminary structural design ensures safe operation without requiring real-time monitoring or user judgment during administration.

Inventive Principle:
Principle #10Preliminary action

3Ease of manufacture

If the nozzle structure is simplified for easy manufacture, then the ease of manufacture is improved, but the manufacturing precision worsens due to difficulty in controlling the exact extension depth

Engineering Contradiction:
Improvestructural simplicityVSAvoidnozzle extension depth control
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The nozzle is divided into distinct functional sections: a columnar end section for depth control, a conical expansion section for medication delivery, and a connecting cylinder for attachment. Each section has standardized dimensions that can be manufactured independently using conventional processes, then assembled to achieve the precise overall geometry required for safe and effective operation.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20240358936A1Atomizing nozzle and nasal drug delivery device
Publication Date: 2024.10.31 WUXI NEST BIOTECHNOLOGY CO LTD
  • US20240358936A1 patent drawing
  • US20240358936A1 patent drawing
  • US20240358936A1 patent drawing

AI summary

The present disclosure discloses an atomizing nozzle and a nasal drug delivery device. The atomizing nozzle includes a spray hood which includes a conical hood body and a connecting cylinder provided inside the hood body and connected to the inner top of the hood body, the wall of the connecting cylinder is provided with a bayonet structure or a claw structure for non-detachable snap fit with the corresponding claw structure or the bayonet structure on the outer side of the syringe extending into the connecting cylinder, a columnar end extends from the external tip of the hood body for extending into the internal nasal cavity, the connecting cylinder, the columnar end and a portion of the hood body therebetween jointly form a communicating channel, the front end of the columnar end is provided with a spray hole, and a fluid-guiding cylinder.